6576.TWO
Price:
$65.6
Market Cap:
$10.15B
Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company's stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; and FP-016 for the treatment of neurological diseases. Its new chemical entity pipeline products consist of FP-020 to treat sarcoidosis, idiopathic pulmonary fibrosis, and pul...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2016-04-12
Stock Exchange
TWO
Ticker
6576.TWO
According to Foresee Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -97.10%. This represents a change of 283.87% compared to the average of -25.30% of the last 4 quarters.
The mean historical ROE of Foresee Pharmaceuticals Co., Ltd. over the last ten years is -45.64%. The current -97.10% ROE has changed 112.77% with respect to the historical average. Over the past ten years (40 quarters), 6576.TWO's ROE was at its highest in in the March 2024 quarter at -10.40%. The ROE was at its lowest in in the September 2024 quarter at -43.78%.
Average
-45.64%
Median
-47.51%
Minimum
-83.27%
Maximum
0%
Discovering the peaks and valleys of Foresee Pharmaceuticals Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 60.43%
Maximum Annual ROE = 0%
Minimum Annual Increase = -Infinity%
Minimum Annual ROE = -83.27%
Year | ROE | Change |
---|---|---|
2024 | -67.61% | -18.81% |
2023 | -83.27% | 60.43% |
2022 | -51.91% | 20.37% |
2021 | -43.12% | 54.45% |
2020 | -27.92% | -Infinity% |
The current ROE of Foresee Pharmaceuticals Co., Ltd. (6576.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-67.59%
5-year avg
-54.76%
10-year avg
-45.64%
Foresee Pharmaceuticals Co., Ltd.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Foresee Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Foresee Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Foresee Pharmaceuticals Co., Ltd.'s ROE?
How is the ROE calculated for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?
What is the highest ROE for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?
What is the 3-year average ROE for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?
What is the 5-year average ROE for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?
How does the current ROE for Foresee Pharmaceuticals Co., Ltd. (6576.TWO) compare to its historical average?